Peripartum cardiomyopathy

Authors

  • Rodolfo Citro Dipartimento Medico-Chirurgico di Cardiologia, AOU San Giovanni di Dio e Ruggi D’Aragona “Scuola Medica Salernitana”, Salerno
  • Roberta Giudice Dipartimento Medico-Chirurgico di Cardiologia, AOU San Giovanni di Dio e Ruggi D’Aragona “Scuola Medica Salernitana”, Salerno
  • Marco Mirra Dipartimento Medico-Chirurgico di Cardiologia, AOU San Giovanni di Dio e Ruggi D’Aragona “Scuola Medica Salernitana”, Salerno
  • Rosa Paolillo Dipartimento Medico-Chirurgico di Cardiologia, AOU San Giovanni di Dio e Ruggi D’Aragona “Scuola Medica Salernitana”, Salerno
  • Chiara Paolillo Dipartimento Medico-Chirurgico di Cardiologia, AOU San Giovanni di Dio e Ruggi D’Aragona “Scuola Medica Salernitana”, Salerno
  • Anna Battimelli Dipartimento Medico-Chirurgico di Cardiologia, AOU San Giovanni di Dio e Ruggi D’Aragona “Scuola Medica Salernitana”, Salerno
  • Gennaro Provenza Dipartimento Medico-Chirurgico di Cardiologia, AOU San Giovanni di Dio e Ruggi D’Aragona “Scuola Medica Salernitana”, Salerno
  • Amelia Ravera Dipartimento Medico-Chirurgico di Cardiologia, AOU San Giovanni di Dio e Ruggi D’Aragona “Scuola Medica Salernitana”, Salerno
  • Rosario Farina Dipartimento Medico-Chirurgico di Cardiologia, AOU San Giovanni di Dio e Ruggi D’Aragona “Scuola Medica Salernitana”, Salerno
  • Cesare Baldi Dipartimento Medico-Chirurgico di Cardiologia, AOU San Giovanni di Dio e Ruggi D’Aragona “Scuola Medica Salernitana”, Salerno

DOI:

https://doi.org/10.7175/rhc.v2i3.31

Keywords:

Peripartum cardiomyopathy, Cardiac failure, Prolactin, Pregnancy

Abstract

Peripartum cardiomyopathy is an uncommon form of congestive heart failure associated with systolic dysfunction of left ventricle. The onset is characterised by symptoms of heart failure occurring between the last month of pregnancy and 5-6 months postpartum. The early diagnosis and the institution of medical treatment for this disease are essential because the inadequate management may affect the patient’s long-term prognosis and can lead to severe complications, including death.

Currently its aetiology is not completely understood. Many aetiopathogenetic hypotheses have been formulated: inflammation, viral agents, autoimmune processes. In the last years, evidences aroused for a role of prolactin and its 16 kDa metabolite in reducing cardiomyocite metabolic activity and contraction. In this article we have reviewed the current literature with special emphasis on the role of prolactin and the related current treatment strategies. In particular, bromocriptine appears promising, even if women need to be informed that the drug stops the production of breastmilk. Further researchers, such as large multicenter trials, are needed to decide the best treatment for the women suffering of this disease.

Downloads

Published

2011-05-19

Issue

Vol. 2 No. 3 (2011)

Section

Narrative reviews

License

Authors who publish with this journal agree to the following terms:
  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
  4. Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)